Jobs / United States / Astrazeneca Pharmaceuticals Lp
Global Clinical Head (Pulmonologist)- Executive Director
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Cambridge Kendall SQ - MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Global Product Teams Finance Director, R&D Finance” (Financial Managers) in MD: $196k–$196k, median $196k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Are you a clinical research expert ready for new opportunities? Would you like to play a pivotal role in the development of potential medicines? If you are passionate about being a medical leader for a cross-functional team in a group that drives action towards the improvement of global public health– join us! As Global Clinical Head (Executive Director) you will have a unique opportunity to further elevate the Infectious Disease Unit in one of the world’s most respected biopharmaceutical companies. The role holds a significant development opportunity for the successful candidate whilst contributing to the positive journey that AstraZeneca is on. Accountabilities: The Global Clinical Head (GCH) will have overall clinical leadership of one or more global product s in the Infectious Disease pipelin e specifically related to the prevention of infections in patients with chronic respiratory diseases . The GCH is also responsible for m edical /s cientific strategies for the clinical components of the Target Product Profile (TPP), Clinical Development Plan (CDP) , and regulatory document s (e.g., briefing documents, CTD/BLA, core labelling texts ) . Within the Clinical Project Team, the GCH has accountability for the clinical, scientific , and value content and delivery of the medical components for the p rogram to time and quality. The GCH will be the team’s voice and representative on the Global Project Team that oversees the overall strategy of Infectio us Disease U nit’s products. Essential Skills/Experience: • Graduate of a recognized school of medicine with an MD degree or equivalent with board-certification in pulmonology • Demonstrated clinical research expertise in Pulmonology (especially in COPD and bronchiectasis) • Pharma industry experience in clinical drug development for at least 10 years • Experience in early and late stage program development and trial conduct • Developed/delivered in parallel multiple complex and /or large studies (e.g., including but not limited to global , pivotal Phase 3 efficacy studies) • Demonstrated ability to lead the development of a program strategy (e.g., Clinical Development Plans) and be accountable for project plans, timelines, progress, and outcomes • Writing and delivery of g lobal regulatory submissions (e.g., NDA/BLA submissions , benefit/risk assessment) and interacting with major Health Authorities (e.g., FDA, EMA, PMDA, CDE) • Demonstrated ability leading and motivating teams in a matrix environment • Demonstrated ability to lead, coach, and mentor physicians and other clinical scientists • Significant hands-on clinical drug development experience and scientific credibility • Demonstrated ability to cultivate excellent cross-functional collaborations • Demonstrated ability to effectively communicate at multiple levels of the organization • Must demonstrate high integrity • Organize and deliver Advisory Boards with international Key Opinion Leaders (KOLs) • Demonstrated AI/digital mindset and experience applying AI-enabled and generative AI tools to support clinical development activities (e.g., data analysis , medical writing , clinical trial operational efficiency ) Desirable Skills/Experience : • Infectious disease and/or vaccine expertise • Named Investigator on a number of clinical trials • Significant and consistent peer-reviewed publication track record When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and c